购物车
全部删除
您的购物车当前为空
UH-NIP-16 对 Mycobacterium tuberculosis(结核分枝杆菌)显示出抑菌效果,能够抑制致病菌株 H37Rv 和 CDC1551,其 MIC50 分别为 1.86 和 3.05 μM。UH-NIP-16 能与抗结核药物如 Streptomycin、Isoniazid、Ethambutol 和 Bedaquiline 等协同运作,增强它们的抗结核活性。
UH-NIP-16 对 Mycobacterium tuberculosis(结核分枝杆菌)显示出抑菌效果,能够抑制致病菌株 H37Rv 和 CDC1551,其 MIC50 分别为 1.86 和 3.05 μM。UH-NIP-16 能与抗结核药物如 Streptomycin、Isoniazid、Ethambutol 和 Bedaquiline 等协同运作,增强它们的抗结核活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
UH-NIP-16 相关产品
| 产品描述 | UH-NIP-16 exhibits antibacterial activity against Mycobacterium tuberculosis, effectively inhibiting the pathogenic mycobacterium strains H37Rv and CDC1551 with MIC50 values of 1.86 and 3.05 μM, respectively. Additionally, UH-NIP-16 synergistically enhances the antitubercular effects when used with antituberculosis agents such as Streptomycin, Isoniazid, Ethambutol, and Bedaquiline. |
| 分子式 | C17H13ClN4O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容